The approved pills changed the maths
Two oral GLP-1s were approved either side of the new year, both starting at $149 a month. That undercuts a large part of the compounded market.
Updated 2026-09-18
If the needle has been the barrier, the situation changed completely in 2026. There are now two approved oral GLP-1s rather than a compounded sublingual workaround.
Both start at $149 a month self-pay. That is more than the cheapest compounded programmes — SuperHealthy Rx is $85 and Trimi is $125 — but it is less than the majority of what we track, and it buys a product the FDA has actually reviewed.
What taking a pill actually involves
Oral semaglutide carries strict timing rules — empty stomach, small sip of water, a wait before eating or taking anything else. Get that wrong and absorption drops. Orforglipron, being a small molecule rather than a peptide, does not carry the same restriction. That difference matters more day to day than the price gap.
Foundayo (orforglipron)
FDA approved 1 April 2026. The first oral small-molecule, non-peptide GLP-1 receptor agonist approved for weight management. Unlike oral semaglutide it is not a peptide, so it has no food-and-water timing restrictions of the same kind.
Self-pay from $149/month for the lowest 0.8 mg dose, about $199/month at 2.5 mg, and roughly $299-$349/month at higher doses.
Self-pay through LillyDirect, with telehealth partners including Ro.
How they compare with what we normally cover
| Option | From | Form | FDA-approved? |
|---|---|---|---|
| Wegovy pill (oral semaglutide) | $149/mo | Daily tablet | Yes |
| Foundayo (orforglipron) | $149/mo | Daily tablet | Yes |
| Cheapest compounded semaglutide (SuperHealthy Rx) | $85/mo | Weekly injection | No |
| Cheapest compounded tirzepatide (Trimi) | $125/mo | Weekly injection | No |
| Typical compounded programme | $189–$449/mo | Weekly injection | No |
| Wegovy injection, self-pay | $199 then $349/mo | Weekly injection | Yes |
Worth knowing. What this does not mean. A pill is not automatically better than an injection. Oral semaglutide has strict instructions about taking it on an empty stomach with a small sip of water and waiting before eating — get that wrong and it underperforms. And the trial weight-loss figures for injectable tirzepatide remain the highest of any of these options.
Who probably should not
If you are already on Trimi or SuperHealthy Rx at under $130 a month, tolerating it well and getting results, the approved pills cost more. That is a real reason to stay put. The comparison changes if your programme raises prices or your dose pushes you into a higher tier.
Whichever direction you are considering, it is a conversation with a prescriber rather than a purchase decision. Both drugs have contraindications, and switching between them is not simply swapping one box for another.
Read next
- Medicare, GLP-1s and the $50 month
CMS is running a time-limited programme giving eligible Part D members certain GLP-1s for $50 a month. If you are on Medicare, read this before paying cash for anything.
- The dose ladder
Why you start low, how fast you climb, and why the price of each rung matters more than people expect.
- Is compounded medication still legal?
Yes, but much more narrowly than in 2024. What changed, and the five questions to ask before you start.
- Tirzepatide or semaglutide?
One produced larger average weight loss in a head-to-head trial. The other is gentler on the wallet and, for some people, on the stomach.
- The cheapest weekly shots
Every programme sorted on what leaves your account each month, with membership fees counted and teaser rates ignored.
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure